Mb, Levis & Associates, LLC Astrazeneca PLC Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 1,481 shares of AZN stock, worth $106,765. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,481
Previous 1,460
1.44%
Holding current value
$106,765
Previous $95.7 Million
13.76%
% of portfolio
0.05%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding AZN
# of Institutions
1,392Shares Held
472MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.96 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...